Bluebird Bio (BLUE)

$0.92 0.05 (5.35%)

16:00 EDT BLUE Stock Quote Delayed 30 Minutes

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Nov 22, 2021

Welcome back, traders! We're getting right into the week with a breakdown of the biggest pre-market stock movers for Monday!

Upcoming IPOs This Week: Vita Coco, Portillo’s and 8 More New Stocks to Watch

7 Gene Editing Stocks Promising to Change our DNA

7 Busted Biotech Stocks Due for a Rebound

Volume:

Previous Close -

Market Cap 62.38M

PE Ratio -1.54

EPS -0.6

Volume (Avg. Vol.) 4.48M

Day's Range $0.92 - $0.98

52-Week Range $0.85 - $5.53

Dividend & Yield N/A (N/A)

BLUE Stock Predictions, Articles, and Bluebird Bio News

Gene Editing Stocks: What BLUE, NTLA, BEAM, CRSP and EDIT Are Doing Today

By William White, InvestorPlace Writer Mar 10, 2021

Gene editing stocks are on the move Wednesday with investors taking extra interest in biotech companies on news from two major players.

BLUE Stock Alert: Why Bluebird Bio Shares Are Plunging Today

By William White, InvestorPlace Writer Feb 16, 2021

Bluebird Bio (BLUE) stock is diving on Tuesday after announcing a suspension of some of its clinical trials due to safety concerns.

7 Cutting-Edge Biotech Stocks for Tomorrow

By Bret Kenwell, InvestorPlace Contributor Oct 28, 2020

Biotech stocks are always going to be here, in good times and bad. Let's look at a few that are worth considering on the long side.

7 Big Biotech Stocks to Avoid

By Louis Navellier, Editor, Growth Investor Jan 28, 2020

The only thing more important than what to buy is what not to buy. These biotech stocks are at the top of the avoid list. Here's why.

Stock Market Today: Buy the Rumor, Sell the News

By Bret Kenwell, InvestorPlace Contributor Dec 13, 2019

A trade deal did not result in the type of action stock market bulls were hoping for. Here's what happened in the stock market today.

5 Top Stock Trades for Tuesday: CHWY, SFIX, SHOP

By Bret Kenwell, InvestorPlace Contributor Dec 9, 2019

Chewy, Toll Brothers, Stitch Fix, bluebird bio and Shopify were our top stock trades from Monday. Here's a look at the charts.

3 Cancer-Fighting Drug Stocks to Buy Right Now

By Aaron Levitt, InvestorPlace Contributor Oct 3, 2019

These drug stocks are among the best to buy now because each is making progress in the fight against cancer. Here's what you should know about each.

7 Big Biotech Stocks to Watch

By Chris Lau, InvestorPlace Contributor Sep 27, 2019

Biotech stocks are still out of favor because of macro uncertainties. But beneath that, investors may find companies trading at deep value.

5 Biotech Stocks for a Long-Lived Portfolio

By Chris Lau, InvestorPlace Contributor Apr 30, 2019

Biotech stocks fell sharply in the last few weeks, mostly on no new news. This drop may have created an entry point for investors.

Bluebird Bio Stock May Have Upside of at Least 60 Percent

By Chris Lau, InvestorPlace Contributor Sep 12, 2018

Bluebird Bio stock fell in the first week of September without reason. When the market notices its growth potential, the BLUE stock could rally.

Play The Future of Gene Therapy With These 5 Biotech Stocks

By Aaron Levitt, InvestorPlace Contributor Aug 27, 2018

What's the next big thing in biotech? The answer is gene therapy and these five biotech stocks are leading the way.

Bluebird Bio Stock Is for Long-Term Investors Only

By InvestorPlace Research Staff Aug 6, 2018

Bluebird bio is worth the risk, if you have the necessary patience to ride any short-term storms. Here's what you need to know about BLUE stock's long-term prospects.

10 Biggest Stock Market Successes of 2017

By James Brumley, InvestorPlace Feature Writer Dec 12, 2017

The year isn't over yet, but these ten names have pretty much secured their place as 2017's biggest and best stories.

The SPDR S&P Biotech (ETF) (XBI) Is on Breakout Watch

By Tyler Craig, Tales of a Technician Jun 14, 2017

Biotech stocks are quietly climbing higher. Here's how to trade the SPDR S&P Biotech (ETF) (XBI) before its seemingly imminent pop.

16 Biotechnology Stocks to Sell Now

By Portfolio Grader Jan 2, 2017

The overall ratings of 16 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").